Back to AXSM
VANGUARD GROUP INC AXSM Position History
Axsome Therapeutics, Inc. • Healthcare
Quarters held
20
Latest value
$3.2M
Q4 2025
Peak value
$697.4M
First seen
Q1 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2025 | $864K |
| Q1 2025 | $3.2M |
| Q1 2025 | $442.1M |
| Q1 2025 | $4.1M |
| Q1 2025 | $1.9M |
| Q2 2025 | $818K |
| Q2 2025 | $3.1M |
| Q2 2025 | $402.1M |
| Q2 2025 | $4.1M |
| Q2 2025 | $1.7M |
| Q3 2025 | $467.7M |
| Q3 2025 | $33.3M |
| Q3 2025 | $3.7M |
| Q3 2025 | $1M |
| Q3 2025 | $2M |
| Q4 2025 | $1.5M |
| Q4 2025 | $5.6M |
| Q4 2025 | $697.4M |
| Q4 2025 | $53M |
| Q4 2025 | $3.2M |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q4 2025 | $3.2M | 17.6K | — | — |
| Q4 2025 | $53M | 290.0K | — | — |
| Q4 2025 | $697.4M | 3.82M | — | — |
| Q4 2025 | $5.6M | 30.4K | — | — |
| Q4 2025 | $1.5M | 8.3K | — | — |
| Q3 2025 | $2M | 16.7K | — | — |
| Q3 2025 | $1M | 8.3K | — | — |
| Q3 2025 | $3.7M | 30.4K | — | — |
| Q3 2025 | $33.3M | 274.1K | — | — |
| Q3 2025 | $467.7M | 3.85M | — | — |
| Q2 2025 | $1.7M | 16.8K | — | — |
| Q2 2025 | $4.1M | 39.4K | — | — |
| Q2 2025 | $402.1M | 3.85M | — | — |
| Q2 2025 | $3.1M | 29.4K | — | — |
| Q2 2025 | $818K | 7.8K | — | — |
| Q1 2025 | $1.9M | 16.7K | — | — |
| Q1 2025 | $4.1M | 35.0K | — | — |
| Q1 2025 | $442.1M | 3.79M | — | — |
| Q1 2025 | $3.2M | 27.1K | — | — |
| Q1 2025 | $864K | 7.4K | — | — |
Other funds holding AXSM
$192.3M
$192.3M
$175M
$166.8M
$163.9M
$141.9M